chitosan has been researched along with Diabetic Glomerulosclerosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, ZL; Lai, CS; Sudirman, S; Yan, YL; Yeh, HI | 1 |
| Lungkaphin, A; Sutthasupha, P | 1 |
| Asfour, MH; Mohsen, AM; Salama, AAA | 1 |
| Chen, QL; Chu, JMT; Hu, YJ; Li, J; Linghu, KG; Wang, YT; Wong, GTC; Xiong, SH; Xiong, W; Yu, H; Zhao, GD | 1 |
| Abdo, SA; Arisha, AH; Ebraheim, LLM; El-Mandrawy, SAM; Khater, SI; Mohamed, AA; Mohammed, AT; Nassan, MA | 1 |
| Chang, IY; Kim, HI; Kim, JH; Kim, JN; Kim, JW; Park, KS; Yoon, SP | 1 |
1 review(s) available for chitosan and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
The potential roles of chitosan oligosaccharide in prevention of kidney injury in obese and diabetic conditions.
Topics: Animals; Chitosan; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Lipid Metabolism; Obesity; Oligosaccharides | 2020 |
5 other study(ies) available for chitosan and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Histological evidence of chitosan-encapsulated curcumin suppresses heart and kidney damages on streptozotocin-induced type-1 diabetes in mice model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chitosan; Curcumin; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Diabetic Nephropathies; Disease Models, Animal; Heart; Kidney; Male; Mice; Mice, Inbred C57BL; Streptozocin | 2019 |
Fabrication of All-Trans Retinoic Acid loaded Chitosan/Tripolyphosphate Lipid Hybrid Nanoparticles as a Novel Oral Delivery Approach for Management of Diabetic Nephropathy in Rats.
Topics: Animals; Chitosan; Diabetes Mellitus; Diabetic Nephropathies; Drug Carriers; Lipids; Nanoparticles; Particle Size; Polyphosphates; Rats; Spectroscopy, Fourier Transform Infrared; Tretinoin; Vascular Endothelial Growth Factor A | 2021 |
Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Chitosan; Diabetic Nephropathies; Dogs; Drug Carriers; Fibrosis; Intestinal Mucosa; Kidney; Madin Darby Canine Kidney Cells; Male; Nanoparticles; Permeability; Polyethylene Glycols; Proof of Concept Study; Rats, Sprague-Dawley; Tight Junctions | 2021 |
Stabilized-chitosan selenium nanoparticles efficiently reduce renal tissue injury and regulate the expression pattern of aldose reductase in the diabetic-nephropathy rat model.
Topics: Aldehyde Reductase; Animals; Chitosan; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Kidney; Kidney Function Tests; Male; Nanoparticles; Rats; Rats, Sprague-Dawley; Selenium | 2021 |
The role of apurinic/apyrimidinic endonuclease on the progression of streptozotocin-induced diabetic nephropathy in rats.
Topics: Animals; Blood Urea Nitrogen; Caspase 3; Chitosan; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; DNA Damage; DNA-(Apurinic or Apyrimidinic Site) Lyase; Enzyme Activators; Male; Nephrons; Organ Size; Rats; Rats, Sprague-Dawley; Streptozocin; Tumor Suppressor Protein p53 | 2012 |